Annual D&A
$2.17 M
-$268.00 K-10.97%
December 31, 2023
Summary
- As of February 7, 2025, CTMX annual depreciation & amortization is $2.17 million, with the most recent change of -$268.00 thousand (-10.97%) on December 31, 2023.
- During the last 3 years, CTMX annual D&A has fallen by -$398.00 thousand (-15.47%).
- CTMX annual D&A is now -19.62% below its all-time high of $2.71 million, reached on December 31, 2021.
Performance
CTMX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$429.00 K
-$30.00 K-6.54%
September 30, 2024
Summary
- As of February 7, 2025, CTMX quarterly depreciation & amortization is $429.00 thousand, with the most recent change of -$30.00 thousand (-6.54%) on September 30, 2024.
- Over the past year, CTMX quarterly D&A has dropped by -$55.00 thousand (-11.36%).
- CTMX quarterly D&A is now -36.91% below its all-time high of $680.00 thousand, reached on September 30, 2021.
Performance
CTMX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$1.84 M
-$55.00 K-2.90%
September 30, 2024
Summary
- As of February 7, 2025, CTMX TTM depreciation & amortization is $1.84 million, with the most recent change of -$55.00 thousand (-2.90%) on September 30, 2024.
- Over the past year, CTMX TTM D&A has dropped by -$456.00 thousand (-19.85%).
- CTMX TTM D&A is now -31.97% below its all-time high of $2.71 million, reached on December 31, 2021.
Performance
CTMX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
CTMX Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -11.0% | -11.4% | -19.9% |
| 3 y3 years | -15.5% | -11.4% | -19.9% |
| 5 y5 years | +15.4% | -11.4% | -19.9% |
CTMX Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -19.6% | at low | -36.4% | at low | -32.0% | at low |
| 5 y | 5-year | -19.6% | at low | -36.9% | at low | -32.0% | at low |
| alltime | all time | -19.6% | +232.1% | -36.9% | +60.1% | -32.0% | +586.9% |
CytomX Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $429.00 K(-6.5%) | $1.84 M(-2.9%) |
| Jun 2024 | - | $459.00 K(-1.7%) | $1.90 M(-7.4%) |
| Mar 2024 | - | $467.00 K(-3.9%) | $2.05 M(-5.9%) |
| Dec 2023 | $2.17 M(-11.0%) | $486.00 K(+0.4%) | $2.17 M(-5.3%) |
| Sep 2023 | - | $484.00 K(-20.7%) | $2.30 M(-5.7%) |
| Jun 2023 | - | $610.00 K(+2.5%) | $2.44 M(0.0%) |
| Mar 2023 | - | $595.00 K(-2.1%) | $2.44 M(-0.3%) |
| Dec 2022 | $2.44 M(-9.7%) | $608.00 K(-2.4%) | $2.44 M(-2.7%) |
| Sep 2022 | - | $623.00 K(+2.1%) | $2.51 M(-2.2%) |
| Jun 2022 | - | $610.00 K(+1.3%) | $2.57 M(-2.5%) |
| Mar 2022 | - | $602.00 K(-10.8%) | $2.63 M(-2.7%) |
| Dec 2021 | $2.71 M(+5.2%) | $675.00 K(-0.7%) | $2.71 M(+0.5%) |
| Sep 2021 | - | $680.00 K(+0.4%) | $2.69 M(+1.1%) |
| Jun 2021 | - | $677.00 K(+0.4%) | $2.67 M(+2.1%) |
| Mar 2021 | - | $674.00 K(+1.8%) | $2.61 M(+1.4%) |
| Dec 2020 | $2.57 M(-1.2%) | $662.00 K(+1.5%) | $2.57 M(+2.1%) |
| Sep 2020 | - | $652.00 K(+4.8%) | $2.52 M(-1.0%) |
| Jun 2020 | - | $622.00 K(-2.4%) | $2.54 M(-1.7%) |
| Mar 2020 | - | $637.00 K(+4.8%) | $2.59 M(-0.6%) |
| Dec 2019 | $2.60 M | $608.00 K(-10.2%) | $2.60 M(+4.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $677.00 K(+1.5%) | $2.50 M(+7.2%) |
| Jun 2019 | - | $667.00 K(+2.1%) | $2.33 M(+9.6%) |
| Mar 2019 | - | $653.00 K(+30.9%) | $2.13 M(+12.8%) |
| Dec 2018 | $1.88 M(+13.4%) | $499.00 K(-2.2%) | $1.88 M(+4.3%) |
| Sep 2018 | - | $510.00 K(+10.2%) | $1.81 M(+1.9%) |
| Jun 2018 | - | $463.00 K(+12.4%) | $1.77 M(+5.6%) |
| Mar 2018 | - | $412.00 K(-2.1%) | $1.68 M(+1.0%) |
| Dec 2017 | $1.66 M(-4.1%) | $421.00 K(-11.7%) | $1.66 M(-4.0%) |
| Sep 2017 | - | $477.00 K(+29.3%) | $1.73 M(+2.0%) |
| Jun 2017 | - | $369.00 K(-6.6%) | $1.70 M(-4.3%) |
| Mar 2017 | - | $395.00 K(-19.4%) | $1.77 M(+2.3%) |
| Dec 2016 | $1.73 M(+43.7%) | $490.00 K(+10.6%) | $1.73 M(+10.2%) |
| Sep 2016 | - | $443.00 K(-0.4%) | $1.57 M(+9.5%) |
| Jun 2016 | - | $445.00 K(+25.4%) | $1.44 M(+11.1%) |
| Mar 2016 | - | $355.00 K(+7.9%) | $1.29 M(+7.2%) |
| Dec 2015 | $1.21 M(+54.0%) | $329.00 K(+7.2%) | $1.21 M(+37.5%) |
| Sep 2015 | - | $307.00 K(+1.7%) | $877.00 K(+53.9%) |
| Jun 2015 | - | $302.00 K(+12.7%) | $570.00 K(+112.7%) |
| Mar 2015 | - | $268.00 K | $268.00 K |
| Dec 2014 | $783.00 K(+19.5%) | - | - |
| Dec 2013 | $655.00 K | - | - |
FAQ
- What is CytomX Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for CytomX Therapeutics?
- What is CytomX Therapeutics annual D&A year-on-year change?
- What is CytomX Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for CytomX Therapeutics?
- What is CytomX Therapeutics quarterly D&A year-on-year change?
- What is CytomX Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for CytomX Therapeutics?
- What is CytomX Therapeutics TTM D&A year-on-year change?
What is CytomX Therapeutics annual depreciation & amortization?
The current annual D&A of CTMX is $2.17 M
What is the all time high annual D&A for CytomX Therapeutics?
CytomX Therapeutics all-time high annual depreciation & amortization is $2.71 M
What is CytomX Therapeutics annual D&A year-on-year change?
Over the past year, CTMX annual depreciation & amortization has changed by -$268.00 K (-10.97%)
What is CytomX Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of CTMX is $429.00 K
What is the all time high quarterly D&A for CytomX Therapeutics?
CytomX Therapeutics all-time high quarterly depreciation & amortization is $680.00 K
What is CytomX Therapeutics quarterly D&A year-on-year change?
Over the past year, CTMX quarterly depreciation & amortization has changed by -$55.00 K (-11.36%)
What is CytomX Therapeutics TTM depreciation & amortization?
The current TTM D&A of CTMX is $1.84 M
What is the all time high TTM D&A for CytomX Therapeutics?
CytomX Therapeutics all-time high TTM depreciation & amortization is $2.71 M
What is CytomX Therapeutics TTM D&A year-on-year change?
Over the past year, CTMX TTM depreciation & amortization has changed by -$456.00 K (-19.85%)